Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling.

Wu, Szu-Yuan; Yang, Wan-Yu; Cheng, Chun-Chia; Lin, Kuan-Hao; Sampurna, Bonifasius Putera; Chan, Suat-Ming; Yuh, Chiou-Hwa.

Afiliação

Wu SY; Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, 41354, Taiwan.
Yang WY; Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, 26546, Taiwan.
Cheng CC; Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, 26546, Taiwan.
Lin KH; Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan.
Sampurna BP; Graduate Institute of Business Administration, Fu Jen Catholic University, Taipei, 24205, Taiwan.
Chan SM; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, 35053, Taiwan.
Yuh CH; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, 35053, Taiwan.

Clin Transl Med ; 10(8): e252, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33377648